Browse wide-ranging research at the frontiers of neuroscience supported by Wu Tsai Neurosciences Institute grants, awards, and training fellowships.
Projects
NeuroRoots, brain/computer interface solution for paralysis
Clinical translation of protein-engineered, matrix-mimetic nerve guidance conduits for peripheral nerve injury
Developing a protein-engineered nerve implant that mimics the biochemical and mechanical cues of native tissue in order to enhance the potential for neural regeneration following injury.
A mobile game for domain adaptation and deep learning in autism healthcare (Seed Grant)
Targeting DNA repair for neuroinflammation in stroke
The wearable ENG: A dizzy attack event monitor
PTS glove passive tactile stimulation for stroke rehab - Renewal
This team is developing wearable stimulation devices to improve limb function after stroke. The technology includes a tactile stimulation method, and the wireless, lightweight, and low-cost wearable computing devices to apply this stimulation.
CPStim: Optimized non-invasive brain stimulation for chronic pain
Deep learning for automated seizure localization
The wearable ENG: a dizzy attack event monitor, Dizzy DX - Renewal
Optimization of the African killifish platform for rapid drug screening for aggregate based neurodegenerative diseases
Rapid and automated educational assessment through the web browser
Remote reliable measurements of movement using a Bluetooth enabled engineered keyboard solve an unmet need in neurological diseases
This team is developing a device that will enable accurate diagnosis of Parkinson’s disease via telemedicine. They initially introduced the technology of Quantitative DigitoGraphy (QDG) using a repetitive alternating finger tapping (RAFT) task on a musical instrument digital interface (MIDI) keyboard and will use Neuroscience: Translate funding for the next stage of device development.
Extracochlear neurostimulation - Auricle
Sensorineural hearing loss is an increasingly prevalent condition that causes disability to over a third of US adults aged over 65. We are developing a breakthrough device to restore high-frequency hearing that preserves residual hearing through a reversible and minimally invasive approach.
A minimally-invasive intracranial pressure microsensor (mICP) for long-term, continuous ambulatory monitoring
Stanford Brain Organogenesis Program (Phase 2)
Developing brain organoids and assembloids – three dimensional brain tissues grown in the lab – to study human brain development, evolution and neuropsychiatric disorders.
Neuro-Omics Initiative (Phase 2)
Creating new tools to help neuroscientists bridge the study of genes and proteins operating in the brain to the study of brain circuits and systems, which could lead to a deeper understanding of brain function and disease.
Topical Hedgehog modulators to enhance motor nerve regeneration after injury and repair
Development and validation of selective novel small molecule therapeutics for Parkinson's Disease
Extended Reality(XR) enhanced behavioral activation for treatment of Major Depressive Disorder
This team has created an extended reality–enhanced implementation of "behavioral activation," one of the most effective forms of evidence-based psychotherapy for major depression. They will use the Neuroscience:Translate award to test the efficacy and scalability of this approach and accelerate the development of extended reality technologies to improve treatment options for major depression.
Autism digital therapy with embedded endpoints and artificial intelligence for progress tracking and adaptive care - Renewal
Development of an extracochlear neurostimulation device to restore hearing – Renewal
Sensorineural hearing loss is an increasingly prevalent condition that causes disability to over a third of US adults aged over 65. This team is developing a breakthrough device to restore high-frequency hearing that preserves residual hearing through a reversible and minimally invasive approach.
Remote reliable measurements of movement using bluetooth enabled engineered keyboard for diagnosis of neurological diseases - Renewal
This team is developing a device that will enable accurate diagnosis of Parkinson’s disease via telemedicine. They initially introduced the technology of Quantitative DigitoGraphy (QDG) using a repetitive alternating finger tapping (RAFT) task on a musical instrument digital interface (MIDI) keyboard and will use Neuroscience: Translate funding for the next stage of device development.